pharma supply chain security

 


Catalog No. (PSC9X8K)  •  US $4,850  •  March 2024


 

The ineffective management of supply chains by manufacturers and distributors has allowed counterfeiters and smugglers to evolve rapidly and become very creative and excel in producing counterfeit medicines and inserting them into the legitimate supply chains, meaning that many fake medicines go undetected. To counter this issue, global organizations, such as the World Health Organization (WHO), the European Union (EU), and the US Food and Drug Administration (FDA), work together to protect the safety and security of patients through pharma supply chain security.


Evolution in Supply Chain Management

DSCSA (Drug Supply Chain Security Act) established a 10-year roadmap with enforcement and adaptations in 2015 and 2018 related to Product Tracing, Product identifiers, Authorized Trading Partners, and Verification.   The last section of the law, is Electronic Drug Distribution Security (EDDS). Among other things, EDDS directs all trading partners to have in place a secure, electronic, and interoperable system for the exchange of transaction documentation [transaction information (TI) and transaction statements (TS)] to enable the tracing of prescription medications.

 

Pharma Supply Chain Security

Graphs, charts, tables and visualizations complement the analysis

 

Pharma Supply Chain Security

Forecasts, projections of future market activity are derived using standard modeling and statistical techniques.

 


What You Will Learn

  • Provides detailed analysis DSCSA strategies, and workflow component factors.
  • Assesses key stakeholders, market dynamics and market demographics.
  • Analyzes therapeutic demand drivers and evaluates readiness in key supply chain segments.
  • Provides market data and forecasts.
  • Profiles market sector participants, their market activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on DSCSA implementation.
  • Evaluates the impact of supply chain security economic, technology, and regulatory factors.

Table of Contents – Pharma Supply Chain Security

Executive Summary

Pharma Supply Chain Security

Drug Safety vs Drug Security

A Paradigm Shift in Healthcare Integrity

DSCSA Objectives

DSCSA Implementation

Overview of Product Tracing

Track and Tracing

Counterfeiting

Packaging for Drug Security

Track and Trace

Tamper Evident Packaging

Enabling Drug Security Technologies

Serialization

Bluetooth

Wireless Options for Drug Security

Near Field Communication

RFID

Wireless Architectures

Digital Healthcare and Cybersecurity

Medical Applications for NFC

UDI

Hospital Inventory Tracking Solutions

In-patient Management

Threats to Drug Security

Physical Security

Blockchain

Counterfeiting

Optical variable devices

Watermark

Security threats

Security foils

Optically Variable Inks/Color shifting Inks

Intaglio printing

Laser marking

Magnetic strip

Micro/nano printing

Hidden imagery

Polarization imagery

Security inks

Nanoparticles

Packaging for Drug Security

Drug Distribution Security

Track and Trace

Unit Dose Packaging

Holograms

Optically Variable Ink

Color Shifting Inks

Enabling Drug Security Technologies

Interoperability

Serialization

Regulations

The Drug Supply Chain Security Act (DSCSA)

DSCSA Requirements for Pharmacies and Retail Entities

United States Legislative Programs

Automation of Reports and Consolidated Orders System (ARCOS)

EU Falsified Medicines Directive

Cost Estimates and Forecasts

Market Participants

AlpVision

Packaging and label protection

Angstrom Technologies

Advast Suisse AG

Covectra

LGPM Pharma

Korber

NucTech

Imaging and Sensing Instrumental Methods

RxScan

TraceLink

TrackTracerx

VISIOTT Pharma Serialization Solutions

Conclusion

Company Profiles

 

Self-administered Injectable Drug Therapies

 

Order Online   Pharma Supply Chain Security

 

 

 


 

This Report is also available from Global Information, Inc.